BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21059650)

  • 21. MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.
    Li XJ; Ji MH; Zhong SL; Zha QB; Xu JJ; Zhao JH; Tang JH
    Arch Med Res; 2012 Oct; 43(7):514-21. PubMed ID: 23085450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of cell growth and invasion by miR-205 in breast cancer.
    Wu H; Zhu S; Mo YY
    Cell Res; 2009 Apr; 19(4):439-48. PubMed ID: 19238171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1.
    Guo L; Zhu Y; Li L; Zhou S; Yin G; Yu G; Cui H
    Cancer Med; 2019 Sep; 8(12):5687-5701. PubMed ID: 31385464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions.
    Reddy SD; Pakala SB; Ohshiro K; Rayala SK; Kumar R
    Cancer Res; 2009 Jul; 69(14):5639-42. PubMed ID: 19584269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer.
    Carvalheira G; Nozima BH; Cerutti JM
    Oncotarget; 2015 Sep; 6(29):28357-70. PubMed ID: 26317551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of Regulatory Effect of MicroRNA-206 on Connexin 43 in Distant Metastasis of Breast Cancer.
    Lin ZJ; Ming J; Yang L; Du JZ; Wang N; Luo HJ
    Chin Med J (Engl); 2016 Feb; 129(4):424-34. PubMed ID: 26879016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
    Wang J; Liang S; Duan X
    J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
    Zhang N; Wang X; Huo Q; Sun M; Cai C; Liu Z; Hu G; Yang Q
    Oncogene; 2014 Jun; 33(24):3119-28. PubMed ID: 23851509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-495 induces breast cancer cell migration by targeting JAM-A.
    Cao M; Nie W; Li J; Zhang Y; Yan X; Guan X; Chen X; Zen K; Zhang CY; Jiang X; Hou D
    Protein Cell; 2014 Nov; 5(11):862-72. PubMed ID: 25070379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis.
    Francart ME; Vanwynsberghe AM; Lambert J; Bourcy M; Genna A; Ancel J; Perez-Boza J; Noël A; Birembaut P; Struman I; Polette M; Gilles C
    Oncogene; 2020 Apr; 39(18):3680-3692. PubMed ID: 32152404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
    Sun FD; Wang PC; Luan RL; Zou SH; Du X
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-204/CREB5 axis regulates vasculogenic mimicry in breast cancer cells.
    Contreras-Sanzón E; Palma-Flores C; Flores-Pérez A; M Salinas-Vera Y; B Silva-Cázares M; A Marchat L; G Avila-Bonilla R; N Hernández de la Cruz O; E Álvarez-Sánchez M; Pérez-Plasencia C; D Campos-Parra A; López-Camarillo C
    Cancer Biomark; 2022; 35(1):47-56. PubMed ID: 35662106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).
    Zhu S; Si ML; Wu H; Mo YY
    J Biol Chem; 2007 May; 282(19):14328-36. PubMed ID: 17363372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular RNA-100219 promotes breast cancer progression by binding to microRNA-485-3p.
    Yao Y; Fang ZZXHSLCNH
    J BUON; 2019; 24(2):501-508. PubMed ID: 31127997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-511 inhibits proliferation and metastasis of breast cancer cells by targeting FGF4.
    Zhang C; Yang T; Jiang H
    J Gene Med; 2020 Sep; 22(9):e3168. PubMed ID: 32023352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.